TriangleFOR PATIENTS · SOURCE READING
Treatment of Childhood Myelodysplastic Syndromes
Source: Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: June 5, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
For information about the treatments listed below, see the Treatment Option Overview section.
Source links and citations
Treatment of newly diagnosed childhood myelodysplastic syndromes (MDS) may include the following:
Source links and citations
Stem cell transplant using blood stem cells from a donor.
Source links and citations
Supportive care, including transfusion therapy and antibiotics.
Source links and citations
Steroid therapy.
Source links and citations
Lenalidomide therapy, for patients with certain gene changes.
Source links and citations
If the MDS becomes acute myeloid leukemia (AML), treatment will be the same as treatment for newly diagnosed AML.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice